Price Alert

Ortho Clinical Diagnostic... (OCDX)

NASDAQ: OCDX · Real-Time Price · USD

17.63

0.16 (0.92%)

At close: Apr 24, 2025, 3:47 PM

Ortho Clinical Diagnostics Statistics

Share Statistics

Ortho Clinical Diagnostics has 0 shares outstanding. The number of shares has increased by null% in one year.

Shares Outstanding	n/a
Shares Change (YoY)	n/a
Shares Change (QoQ)	n/a
Owned by Institutions (%)	n/a
Shares Floating	n/a
Failed to Deliver (FTD) Shares	n/a
FTD / Avg. Volume	n/a

Short Selling Information

The latest short interest is 7.02M, so 0% of the outstanding shares have been sold short.

Short Interest	7.02M
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	6.31

Valuation Ratios

The PE ratio is -94.44 and the forward PE ratio is null. Ortho Clinical Diagnostics's PEG ratio is 1.22.

PE Ratio	-94.44
Forward PE	n/a
PS Ratio	2.51
Forward PS	n/a
PB Ratio	12.49
P/FCF Ratio	17.89
PEG Ratio	1.22

Financial Ratio History

Enterprise Valuation

Currently the Enterprise Value (EV) is not available for Ortho Clinical Diagnostics.

EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 1.75, with a Debt / Equity ratio of 5.48.

Current Ratio	1.75
Quick Ratio	1.22
Debt / Equity	5.48
Debt / EBITDA	8.88
Debt / FCF	7.85
Interest Coverage	0.82

Financial Efficiency

Return on Equity is n/a and Return on Invested Capital is n/a.

Return on Equity	n/a
Return on Assets	n/a
Return on Invested Capital	n/a
Revenue Per Employee	$425.58K
Profits Per Employee	$-11.31K
Employee Count	4,800
Asset Turnover	0.61
Inventory Turnover	3.3

Taxes

Income Tax	28.3M
Effective Tax Rate	-108.85%

Stock Price Statistics

The stock price has increased by 0% in the last 52 weeks. The beta is 0, so Ortho Clinical Diagnostics's price volatility has been lower than the market average.

Beta	0
52-Week Price Change	n/a
50-Day Moving Average	18.11
200-Day Moving Average	n/a
Relative Strength Index (RSI)	49.29
Average Volume (20 Days)	1,007,226

Income Statement

In the last 12 months, Ortho Clinical Diagnostics had revenue of 2.04B and earned -54.3M in profits. Earnings per share was -0.22.

Revenue	2.04B
Gross Profit	1.04B
Operating Income	120M
Net Income	-54.3M
EBITDA	253.4M
EBIT	120M
Earnings Per Share (EPS)	-0.22

Full Income Statement

Balance Sheet

The company has 309.7M in cash and 2.25B in debt, giving a net cash position of -1.94B.

Cash & Cash Equivalents	309.7M
Total Debt	2.25B
Net Cash	-1.94B
Retained Earnings	-1.97B
Total Assets	n/a
Working Capital	n/a

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 286.6M and capital expenditures 0, giving a free cash flow of 286.6M.

Operating Cash Flow	286.6M
Capital Expenditures	n/a
Free Cash Flow	286.6M
FCF Per Share	1.18

Full Cash Flow Statement

Margins

Gross margin is 50.71%, with operating and profit margins of 5.87% and -2.66%.

Gross Margin	50.71%
Operating Margin	5.87%
Pretax Margin	-1.27%
Profit Margin	-2.66%
EBITDA Margin	12.4%
EBIT Margin	5.87%
FCF Margin	14.03%

Dividends & Yields

OCDX does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Payout Ratio	n/a
Earnings Yield	n/a
FCF Yield	n/a

Dividend Details

Analyst Forecast

Currently there are no analyst rating for OCDX.

Price Target	n/a
Price Target Difference	n/a
Analyst Consensus	n/a
Analyst Count	n/a

Stock Forecasts

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	n/a